0.8371
price up icon2.72%   0.0222
after-market Dopo l'orario di chiusura: .81 -0.0271 -3.24%
loading

Galmed Pharmaceuticals Ltd Borsa (GLMD) Ultime notizie

pulisher
08:26 AM

What drives Galmed Pharmaceuticals Ltd stock priceAutomated Trading Signals & Free Unlock Hidden Market Opportunities - earlytimes.in

08:26 AM
pulisher
Nov 20, 2025

Key metrics from Galmed Pharmaceuticals Ltd.’s quarterly dataJuly 2025 Sector Moves & Verified Stock Trade Ideas - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Can swing trading help recover from Galmed Pharmaceuticals Ltd. lossesTrade Ideas & Daily Profit Maximizing Tips - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Galmed Pharmaceuticals Ltd. (GPH) stock resilient in recession scenarios - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Galmed Pharmaceuticals Ltd. (GPH) stock good for long term investingMarket Performance Report & Free Safe Entry Trade Signal Reports - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Is Galmed Pharmaceuticals Ltd. (GPH) stock suitable for passive index fundsWeekly Trading Summary & Verified Momentum Watchlists - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why Galmed Pharmaceuticals Ltd. stock attracts global investorsWeekly Gains Summary & Detailed Earnings Play Strategies - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Galmed Pharmaceuticals Reveals Promising Results in Oncology Drug Combination Study - MSN

Nov 19, 2025
pulisher
Nov 19, 2025

How buyback programs support Galmed Pharmaceuticals Ltd. (GPH) stock2025 Macro Impact & AI Enhanced Trading Alerts - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Views of Wall Street’s Leading Experts on Galmed Pharmaceuticals Ltd - Setenews

Nov 18, 2025
pulisher
Nov 18, 2025

Galmed Pharmaceuticals Reports Promising Results from Aramchol Meglumine Study - TipRanks

Nov 18, 2025
pulisher
Nov 18, 2025

Galmed announces meaningful top line results from AM-001 study of Aramchol meglumine - MarketScreener

Nov 18, 2025
pulisher
Nov 18, 2025

Galmed (NASDAQ: GLMD) AM-001 shows 5-fold, 3-fold Aramchol bioavailability improvement - Stock Titan

Nov 18, 2025
pulisher
Nov 18, 2025

Galmed reports 3-drug combo enhances cancer treatment efficacy By Investing.com - Investing.com Canada

Nov 18, 2025
pulisher
Nov 17, 2025

Is Galmed Pharmaceuticals Ltd. (GPH) stock positioned for digital growth eraTrade Volume Summary & Fast Moving Market Watchlists - newser.com

Nov 17, 2025
pulisher
Nov 17, 2025

Is It Time to Reconsider Galmed Stock? - StocksToTrade

Nov 17, 2025
pulisher
Nov 17, 2025

Galmed Pharmaceuticals Ltd. (GLMD) Stock: Soars 10.85% Following Breakthrough Cancer Treatment Results - parameter.io

Nov 17, 2025
pulisher
Nov 17, 2025

NASDAQ:GLMD News 17 November 2025 - ts2.tech

Nov 17, 2025
pulisher
Nov 17, 2025

Galmed Pharmaceuticals (GLMD) Soars on New Cancer Drug Combo Data: What Today’s Breakthrough Means for Investors – November 17, 2025 - ts2.tech

Nov 17, 2025
pulisher
Nov 17, 2025

Galmed stock soars after promising cancer treatment research results By Investing.com - Investing.com Nigeria

Nov 17, 2025
pulisher
Nov 17, 2025

Galmed Pharmaceuticals: Is It A Turnaround Story? - timothysykes.com

Nov 17, 2025
pulisher
Nov 17, 2025

Galmed stock soars after promising cancer treatment research results - Investing.com

Nov 17, 2025
pulisher
Nov 17, 2025

Galmed reports 3-drug combo enhances cancer treatment efficacy - Investing.com

Nov 17, 2025
pulisher
Nov 17, 2025

Galmed Announces Top-line Results in Oncology MoA Studies: A 3-drug combination of Aramchol, Stivarga® and Metformin Significantly Enhanced GI Tumor Cells, Killing In-vivo and In-vitro - WV News

Nov 17, 2025
pulisher
Nov 16, 2025

How Galmed Pharmaceuticals Ltd. stock performs after earningsBreakout Watch & Risk Adjusted Swing Trade Ideas - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

How Galmed Pharmaceuticals Ltd. stock reacts to inflationary pressuresTrade Risk Summary & Comprehensive Market Scan Insights - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Galmed Pharmaceuticals Ltd Stock Analysis and ForecastResistance Breakout Alerts & Rapid Wealth Accumulation - earlytimes.in

Nov 15, 2025
pulisher
Nov 12, 2025

Why Galmed Pharmaceuticals Ltd. stock is trending among retail traders2025 Volatility Report & AI Driven Stock Movement Reports - newser.com

Nov 12, 2025
$38.92
price up icon 1.38%
$30.45
price up icon 1.36%
$102.06
price up icon 0.29%
$95.59
price down icon 1.42%
biotechnology ONC
$347.72
price down icon 0.45%
$198.76
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):